About
Eli Lilly appears at No. 71 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Indianapolis, Indiana, United States and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $72.3B in sales, $25.3B in profit, $116.6B in assets and a market value of $946.4B.